American Journal of Public Health
Volume 106, Issue 4 (April 2016)
http://ajph.aphapublications.org/toc/ajph/current

.
AJPH EDITORIALS
ZIKA Preventing Zika Virus Infections in Pregnant Women: An Urgent Public Health Priority
American Journal of Public Health: April 2016, Vol. 106, No. 4: 589–590.
Beth P. Bell, Coleen A. Boyle, Lyle R. Petersen
[No abstract]

AJPH SPECIAL SECTION: ZIKA
Aedes Rides Again: Mosquitoes and Flaviviruses in the Americas
American Journal of Public Health: April 2016, Vol. 106, No. 4: 596–597.
John McNeill

Initial Description of the Presumed Congenital Zika Syndrome
American Journal of Public Health: April 2016, Vol. 106, No. 4: 598–600.
Demócrito de Barros Miranda-Filho, Celina Maria Turchi Martelli, Ricardo Arraes de Alencar Ximenes, Thalia Velho Barreto Araújo, Maria Angela Wanderley Rocha, Regina Coeli Ferreira Ramos, Rafael Dhalia, Rafael Freitas de Oliveira França, Ernesto Torres de Azevedo Marques Júnior, Laura Cunha Rodrigues

The Epidemic of Zika Virus–Related Microcephaly in Brazil: Detection, Control, Etiology, and Future Scenarios
American Journal of Public Health: April 2016, Vol. 106, No. 4: 601–605.
Maria G. Teixeira, Maria da Conceição N. Costa, Wanderson K. de Oliveira, Marilia Lavocat Nunes, Laura C. Rodrigues

History, Epidemiology, and Clinical Manifestations of Zika: A Systematic Review
American Journal of Public Health: April 2016, Vol. 106, No. 4: 606–612.
Enny S. Paixão, Florisneide Barreto, Maria da Glória Teixeira, Maria da Conceição N. Costa, Laura C. Rodrigues

Human Papillomavirus Vaccination in the United States: Uneven Uptake by Gender, Race/Ethnicity, and Sexual Orientation
American Journal of Public Health: April 2016, Vol. 106, No. 4: 746–747.
Jason Daniel-Ulloa, Paul A Gilbert, Edith A. Parker
Abstract
Objectives. To assess national differences in human papillomavirus (HPV) vaccine uptake among young adults in the United States by gender, race/ethnicity, and sexual orientation.
Methods. We tested group differences in initiation and completion of the HPV vaccine series (i.e., 3 doses) by Rao–Scott χ2 test among 6444 respondents aged 18 to 30 years from the 2013 National Health Interview Survey.
Results. Among men, 5% reported receiving the HPV vaccine, with no differences in uptake by race/ethnicity or sexual orientation. By contrast, 30% of the women reported receiving the HPV vaccine, with women of color having lower odds of initiating and completing the vaccine series compared with White women.
Conclusions. In the United States, HPV vaccine rates are lagging in men and show disparities among women. Increasing HPV vaccine uptake and series completion among women of color and all men may provide considerable long-term public health benefits.